Scilex Holding (SCLX) Interest Expenses (2020 - 2026)
Scilex Holding (SCLX) posted quarterly Interest Expenses of $15.0 million for Q1 2026, up 273.32% year-over-year from $4.0 million in Q1 2025, and up 1539.8% quarter-over-quarter from $912000.0 in Q4 2025.
Scilex Holding (SCLX) Interest Expenses (2020 - 2026) Analysis & Trends
Scilex Holding's Interest Expenses history runs 7 years deep, the most recent figure standing at $15.0 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 273.32% year-over-year to $15.0 million; the TTM figure through Mar 2026 stood at $15.0 million (up 273.32% YoY), while the FY2025 annual figure was $11.5 million, down 89.92% from the prior year.
- Interest Expenses for Q1 2026 stood at $15.0 million, up from $912000.0 in the prior quarter.
- The five-year high for Interest Expenses was $112.0 million in Q1 2023, with the low at $8280.0 in Q2 2022.
- The 5-year median for Interest Expenses is $4.0 million (2023), against an average of $13.4 million.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses jumped 786361.35% in 2023, then tumbled 96.42% in 2024.
- Scilex Holding's Interest Expenses stood at $1.0 million in 2022, then slumped by 50.0% to $504000.0 in 2023, then sank by 43.45% to $285000.0 in 2024, then jumped by 220.0% to $912000.0 in 2025, then soared by 1539.8% to $15.0 million in 2026.
- Business Quant data shows SCLX's Interest Expenses at $15.0 million in Q1 2026, $912000.0 in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 462.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 435.00 Mn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -244.19 Mn |
| 10 | Scilex Holding | 39.22 Mn | -73.57 Mn | 3.97 Mn | 6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.96 Mn |
| Mar 31, 2026 | 14.96 Mn |
| Dec 31, 2025 | 912,000.00 |
| Dec 31, 2025 | 912,000.00 |
| Sep 30, 2025 | 4.08 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 4.01 Mn |
| Mar 31, 2025 | 4.01 Mn |
| Dec 31, 2024 | 285,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 4.01 Mn |
| Sep 30, 2024 | 4.01 Mn |
| Jun 30, 2024 | 6.66 Mn |
| Jun 30, 2024 | 6.66 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Dec 31, 2023 | 504,000.00 |
| Dec 31, 2023 | 504,000.00 |